Serum levels of clomipramine and desmethylclomipramine and clinical improvement in panic disorder

Journal of Psychopharmacology

Volumn 13, Issue 1, 1999, Pages 40-44

  Marcourakis, Tania ^a   Gorenstein, C ^b   Ramos, R T ^b   Da Motta Singer, J ^b  

^a LIM 15 Ctro Investigacoes em N   (Brazil)

^b NONE

Author keywords

Clomipramine; Desmethylclomipramine; Panic disorder; Plasma levels

Indexed keywords

CLOMIPRAMINE; NORCLOMIPRAMINE;

ADULT; AGORAPHOBIA; ANXIETY NEUROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PANIC; PRIORITY JOURNAL; RATING SCALE; SELF EVALUATION; SINGLE BLIND PROCEDURE; STATISTICAL ANALYSIS;

EID: 0033035883     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119901300105     Document Type: Article

References (27)

1. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd rev. edn. American Psychiatric Press, Washington, DC
2. Beck A T, Luand C H, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatr 4: 53-61
3. Broadhurst A D, James H D, Della Corte L, Heeley A F (1977) Clomipramine plasma levels and clinical response. Postgrad Med J 53 (Suppl. 4): 139-145
4. Brunello N, Langer S Z, Perez J, Racagni G (1995) Current understanding of the mechanism of action of classic and newer antidepressant drugs. Depression 2: 119-126
5. Charney D S, Heninger G R (1985) Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment. Arch Gen Psychitr 42: 473-481
6. Delgado P L, Gelenberg A J (1995) Antidepressant and antimanic medications. In: Gabbard G O (ed.), Treatments of psychiatric disorders. American Psychiatric Press, Washington, DC
7. Della Corte L, Broadhurst A D, Sgaragli G P, Filipini S, Heeley A F, James H D, Faravelli C, Pazzagli A (1979) Clinical response and tricyclic plasma levels during treatment with clomipramine. Br J Psychiatr 134: 390-400
8. Faravelli C, Broadhurst A D, Ambonetti A, Ballerini A, De Biase L, La Malfa G, Das M (1983) Double-blind trial with oral versus intravenous clomipramine in primary depression. Biol Psychiatr 18: 695-706
9. Faravelli C, Ballerine A, Ambonetti A, Broadhurst A D, Das M (1984) Plasma levels and clinical response during treatment with clomipramine. J Affect Disord 6: 95-107
10. Gentil V (1986) Fisiopatologia da síndrome do pânico. Rev Assoc Med Brasil 32: 121-127
11. Gentil V, Lotufo-Neto F, Andrade L, Cordás T, Bernik M, Ramos R, Maciel L, Miyakawa E, Gorenstein C (1993) Clomipramine, a better reference drug for panic/agoraphobia. I. Effectiveness comparison with impramine. J Psychopharmacol 7: 316-324
12. Greenblatt D J, Harmatz J S, Shader R I (1993) Plasma alprazolam concentrations. Relation to efficacy and side-effects in the treatment of panic disorder. Arch Gen Psychiatr 50: 715-722
13. Guy W (1976) ECDEU assessment manual for psychopharmacology, revised. NIMHANS 76/338, pp. 217-222. US Government Printing Office, Washington, DC
14. Guyon F, Ni P, Jezequiel M, Dupeyron J P (1987) Dosage de la clomipramine et de son dérivé déméthylé par chromatografie en phase liquide. Ann Biol Clin 45: 157-159
15. Hullin R P (1980) Variation in plasma concentrations of clomipramine and desmethylclomipramine during clomipramine therapy. Postgrad Med J 56 (Suppl. 1): 117-119
16. Linnoila M, Seppala T, Mattila M J, Vihko R, Pakarinen A, Skinner J T (1980) Clomipramine and doxepine in depressive neurosis. Arch Gen Psychiatr 37: 1295-1299
17. Lotufo-Neto F, Gentil V, Bernik M, Ramos, R, Cordas, TA, Gorenstein C, Melo, M, Andrade L (1994) Clomipramine double-blind discontinuation in panic disorder patients. Neuropsychopharmacology 10: 11S
18. Modigh K (1987) Antidepressant drugs in anxiety disorders Acta Psychiatr Scand 76 (Suppl. 335): 57-74
19. Noguchi T, Shimoda K, Takahashi S (1993) Clinical significance of plasma levels of clomipramine, its hydroxylated and desmethylated metabolites: prediction of clinical outcome in mood disorders using discriminant analysis of therapeutic drug monitoring data. J Affect Disord 29: 267-279
20. Pascalis G, Wargny E, Lamiable D, Havet J M (1987) Clomipramine et déméthylclomipramine. Corrélation taux plasmatique/efficacité chez 24 déprimés. Encéphale 13: 239-244
21. Piollet I, Goyot C, Paire M, Touzery A, Eschalier A, Dehennin L, Grenier J, Lavarenne J, Zarafian E (1988) Etude des concentration plasmatique de la clomipramine et de son dérive démétilé chez l'homme. Limites méthodologiques. Encéphale 14: 287-292
22. Reisby N, Gram F, Beck F, Sihm F, Krautwald O, Elley J, Ortmann J, Christiansen J (1979) Clomipramine: plasma levels and clinical effect. Commun Psychopharmacology 3: 341-351
23. Sheehan D V (1983) The anxiety disease. Charles Schriber's Sons, New York
24. Traskman L, Asberg M, Bertilsson L, Cronholm B, Mellstrom B, Neckers L M, Sjoqvist F, Thoren P, Tybring G (1979) Plasma levels of clomipramine and its demethyl metabolite during treatment of depression. Clin Pharmacol Ther 26: 600-610
25. Vandel B, Vandel S, Jounet J M, Allers G, Volmat R (1981) Clomipramine et desméthylclomipramine. Relation entre les concentration plasmatique et l'effet clinique. Encéphale VII: 601-608
26. Vandel B, Vandel S, Jounet J M, Allers G, Volmat R (1982) Relationship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and the clinical response. Eur J Clin Pharmacol 22: 15-20
27. Wargny E, Lamiable D, Havet J M, Denis J, Milliart H, Choisy H, Pascalis G (1986) Concentrations plasmatiques de clomipramine et de déclomipramine chez des patients atteints de dépression: recherche de corrélation avec l'efficacité thérapeutique. Ann Med Psychol (Paris) 144: 396-406